Drugs / REVIPARIN SODIUM
REVIPARIN SODIUM
also known as
Clivarin · Clivarine · LU-47311 · reviparin · Reviparina de sodio · Reviparine sodique
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01164046 Comparator | Aug 2010 → Jul 2014 | neoplasm, venous thromboembolism | University Medical Center Groningen | Terminated | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | REVIPARIN SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |
| Known as | Clivarin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |
| Known as | Clivarine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |
| Known as | LU-47311 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |
| Known as | reviparin | “reviparin” NCT01164046 ↗ |
| Known as | Reviparina de sodio | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |
| Known as | Reviparine sodique | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107886 ↗ |